The Psychedelic Therapy Workbook: Harm Reduction Techniques for Integrating Psychedelics in Therapy and Personal Growth

Unlock the healing and transformative benefits of psychedelic therapy with this powerful, practical, evidence-based guide.

If you've sought conventional treatment for depression, anxiety, substance-use disorder, or post-traumatic stress disorder (PTSD) and have been disappointed by a lack of positive results, know that you're not alone. The good news is that there is hope. More and more, research shows the tremendous benefit of psychedelic drugs like psilocybin, MDMA, LSD, and ketamine for people suffering from difficult-to-treat mental health issues. But how do you integrate them into your life effectively?

In The Psychedelic Therapy Workbook, psychologists Elizabeth Nielson and Ingmar Gorman present a pioneering approach to maximizing the therapeutic potential of psychedelics. Drawing on their extensive experience and research, the authors introduce their psychedelic harm reduction and integration (PHRI) method, offering a comprehensive framework for integrating the lessons you've learned from psychedelic experiences into your daily life.

With this step-by-step guide, you will:

• Learn how to choose the right setting and set intentions for a positive experience
• Explore evidence-based practices to ensure healing and growth
• Empower yourself to navigate the psychedelic landscape with confidence and mindfulness

Whether you're embarking on a therapeutic journey on your own, in a group, or with a therapist, this workbook provides the tools you need to explore the benefits of psychedelics for profound transformation, healing, and self-discovery.

Author: Elizabeth Nielson, Ingmar Gorman
Binding Type: Paperback
Publisher: New Harbinger Publications
Published: 05/01/2025
Pages: 184
ISBN: 9781648484254

About the Author

Elizabeth Nielson, PhD, is a psychologist and cofounder of Fluence with an expertise in psychedelic therapist training. She has worked on developing psychedelic therapies through conduct of FDA-approved trials of psychedelics for PTSD, substance use problems, and mood disorders, and she has published research on psychedelic therapies and psychedelic therapist training. Nielson has also worked as an educator for clinicians for over a decade and continues to create training programs to ensure the highest quality care for psychedelic users.

Ingmar Gorman, PhD, is a psychologist and cofounder of Fluence, specializing in psychedelic education for mental health providers. His extensive clinical training and experience includes prestigious institutions in New York City. Notably, Gorman contributes to FDA-approved clinical trials of psychedelic treatments, and has published extensively on psychedelics and harm reduction.